Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database
暂无分享,去创建一个
Sushil Ghimire | Prakash Acharya | Dilli Ram Poudel | Rashmi Dhital | Rajani Bharati | P. Acharya | R. Dhital | Sushil Ghimire | D. Poudel | Rajani Bharati
[1] N. Laird,et al. Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .
[2] K Henriksen,et al. Using ICD-9-CM Codes in Hospital Claims Data to Detect Adverse Events in Patient Safety Surveillance -- Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 1: Assessment) , 2008 .
[3] Wu Xu,et al. Performance of International Classification of Diseases, 9th Revision, Clinical Modification Codes as an Adverse Drug Event Surveillance System , 2006, Medical care.
[4] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[5] Max Petzold,et al. Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis , 2012, PloS one.
[6] D. Bates,et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. , 1997, Critical care medicine.
[7] Emily R. Hajjar,et al. Polypharmacy in elderly patients. , 2007, The American journal of geriatric pharmacotherapy.
[8] International drug monitoring: the role of national centres. Report of a WHO meeting. , 1972, World Health Organization technical report series.
[9] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[10] Wu Xu,et al. Using ICD-9-CM Codes in Hospital Claims Data to Detect Adverse Events in Patient Safety Surveillance , 2008 .
[11] Tom Fahey,et al. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study , 2015, BMJ Open.
[12] J Mainz,et al. How are medication errors defined? A systematic literature review of definitions and characteristics. , 2010, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[13] Cordula Wagner,et al. Potentially inappropriate medication use among elderly home care patients in Europe. , 2005, JAMA.
[14] J. Stephens,et al. Published costs of Medication errors leading to preventable adverse Drug events in US Hospitals , 2015 .
[15] A. Elixhauser,et al. Characteristics of Adverse Drug Events Originating During the Hospital Stay, 2011 , 2013 .
[16] R. Jiménez-García,et al. Trends of adverse drug reactions related-hospitalizations in Spain (2001-2006) , 2010, BMC health services research.
[17] D. Bates,et al. Global priorities for patient safety research , 2009, BMJ : British Medical Journal.
[18] Azeem Majeed,et al. Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009 , 2010, Journal of the Royal Society of Medicine.
[19] J. Rivera,et al. Prevalence of Polypharmacy, Polyherbacy, Nutritional Supplement Use and Potential Product Interactions among Older Adults Living on the United States-Mexico Border , 2009, Drugs & aging.
[20] P. Corey,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .
[21] A. Jemal,et al. Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.
[22] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[23] Atholl Johnston,et al. Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. , 2002, Clinical therapeutics.
[24] Jennifer S. Haas,et al. Trends in Prescription Drug Use Among Adults in the United States From 1999–2012 , 2016 .
[25] G. Tognoni,et al. Primary care as a permanent setting for researcha , 2012, Primary Health Care Research & Development.
[26] P. Noyce,et al. Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies , 2008, The Annals of pharmacotherapy.
[27] Josip Car,et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005 , 2007, BMC clinical pharmacology.
[28] Andrew T Chan,et al. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. , 2015, JAMA.
[29] K. Alavi,et al. Working with Existing Databases , 2013, Clinics in Colon and Rectal Surgery.
[30] Catherine Yoon,et al. The costs of adverse drug events in community hospitals. , 2012, Joint Commission journal on quality and patient safety.
[31] D. Bates,et al. The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .
[32] K. Fahrbach,et al. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. , 2004, Chest.
[33] L. Thorndike. Calculator , 1932, Speculum.
[34] M. Cesari,et al. Adverse Drug Reactions as Cause of Hospital Admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) , 2002, Journal of the American Geriatrics Society.
[35] D. Classen,et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.
[36] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[37] Jürgen Stausberg,et al. International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA , 2014, BMC Health Services Research.
[38] M. Pirmohamed,et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.
[39] F. Federico,et al. Preventing medication errors. , 2000, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[40] Miriam C.J.M. Sturkenboom,et al. Adverse Drug Reaction-Related Hospitalisations , 2006, Drug safety.